Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PHR
PHR logo

PHR Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
8.560
Open
8.560
VWAP
8.35
Vol
3.51M
Mkt Cap
510.41M
Low
8.115
Amount
29.31M
EV/EBITDA(TTM)
15.50
Total Shares
60.76M
EV
536.67M
EV/OCF(TTM)
6.81
P/S(TTM)
1.06
Phreesia, Inc. is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations. The Company's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration, and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. Its Technology solutions segment provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The Company's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.
Show More

Events Timeline

(ET)
2026-03-31
16:30:00
Dow Jones Index Rises 2.49% to 46,341.51
select
2026-03-31
12:00:00
Major Averages Surge, S&P 500 and Nasdaq Weakest Since 2022
select

News

NASDAQ.COM
4.5
03-31NASDAQ.COM
US Stocks Surge on Hopes for End to Iran War
  • Market Rally: The S&P 500 index rose by 2.91%, the Dow Jones Industrial Average by 2.49%, and the Nasdaq 100 by 3.43%, reflecting market optimism regarding the potential end of the Iran war, which could lower energy prices and ease inflation concerns.
  • Consumer Confidence Boost: The US March consumer confidence index unexpectedly increased by 0.8 to 91.8, surpassing the anticipated decline to 87.9, indicating a strengthening consumer outlook that may drive spending and economic growth.
  • Strength in China: China's March manufacturing PMI rose to 50.4, better than the expected 50.1, signaling signs of economic recovery that could positively impact global growth prospects and further support US stock performance.
  • Falling Bond Yields: The 10-year Treasury note yield dropped to 4.28%, a one-week low, reflecting reduced inflation worries, which may provide support for the stock market and enhance investor interest in equities.
NASDAQ.COM
2.0
03-31NASDAQ.COM
Phreesia Inc Shares Enter Oversold Territory
  • Oversold Signal: Phreesia Inc (Ticker: PHR) saw its RSI drop to 26.0 during Tuesday's trading, indicating that its stock price, which hit a low of $7.77, has entered oversold territory, suggesting that recent heavy selling may be nearing exhaustion and providing potential buying opportunities for investors.
  • Market Comparison: Compared to the current RSI of 43.5 for the S&P 500 ETF (SPY), PHR's oversold condition may attract bullish investors, particularly in a market where overall performance remains relatively strong, potentially leading to increased capital inflow.
  • Price Volatility: With a 52-week low of $7.77 and a high of $32.76, PHR's current trading price of $8.38 indicates significant price fluctuations, suggesting potential for a rebound that may catch the attention of short-term traders.
  • Investor Sentiment: Despite the current low stock price, investor sentiment towards PHR may turn optimistic due to the oversold signal, especially as interest in other oversold stocks rises, which could drive its stock price higher.
NASDAQ.COM
4.5
03-31NASDAQ.COM
US Stocks Surge as Market Sentiment Improves
  • Market Sentiment Improves: The S&P 500 index rose by 1.02%, the Dow Jones Industrial Average increased by 0.67%, and the Nasdaq 100 surged by 1.10% as President Trump signaled a willingness to end military actions against Iran, reflecting investor optimism over easing geopolitical risks.
  • Falling Bond Yields: The 10-year Treasury note yield dropped to a one-week low of 4.30%, indicating market expectations that an end to the Iran conflict could lower energy prices and alleviate inflation concerns, further supporting stock market gains.
  • Consumer Confidence Rises: The US March consumer confidence index unexpectedly increased by 0.8 to 91.8, surpassing expectations of a decline to 87.9, suggesting enhanced consumer confidence in economic prospects, which could drive spending and economic growth.
  • Strong Chinese Economy: China's March manufacturing PMI rose to 50.4, exceeding expectations of 50.1, indicating signs of economic recovery that support global growth prospects and positively influence market performance.
Fool
9.5
03-31Fool
Phreesia Stock Plummets After Mixed Q4 Earnings Report
  • Earnings Report Disappointment: Phreesia's Q4 2026 earnings report revealed a revenue of $127.1 million, surpassing expectations, yet the earnings per share of $0.02 fell significantly short of the anticipated $0.06, resulting in a 27.5% stock drop in early trading.
  • Sales Growth Highlight: Despite the earnings miss, Phreesia achieved a 16% year-over-year sales increase and reported profitability for both the quarter and the full year at $0.04 per share, indicating some resilience in the market.
  • Free Cash Flow Performance: The company generated a positive free cash flow of $28.5 million for the quarter and $54.4 million for the year, reflecting a solid cash position after accounting for capital expenditures and software costs, despite the earnings challenges.
  • Cautious Future Outlook: Phreesia lowered its fiscal 2027 revenue guidance to $510 million to $520 million from a previous range of $545 million to $559 million, highlighting uncertainty regarding spending commitments from pharmaceutical clients, although it still anticipates a 7% growth.
NASDAQ.COM
2.0
03-31NASDAQ.COM
US Stocks Surge as Market Sentiment Improves
  • Market Rebound: The S&P 500 Index rose by 1.33%, the Dow Jones Industrial Average increased by 1.10%, and the Nasdaq 100 Index climbed by 1.45%, reflecting investor optimism following President Trump's willingness to end military actions against Iran, potentially easing geopolitical tensions.
  • Supportive Economic Data: China's March manufacturing PMI rose by 1.4 to 50.4, surpassing expectations of 50.1, indicating signs of economic recovery that could enhance global growth prospects and drive stock markets higher.
  • Falling Bond Yields: The 10-year T-note yield dropped to 4.30%, a one-week low, as WTI crude oil prices fell, alleviating inflation concerns and lowering borrowing costs, thereby supporting further gains in the stock market.
  • Tech Stocks Lead Gains: The
stocktwits
9.5
03-31stocktwits
PEPG, SGMO, and PHR Shares Decline Amid Disappointing Results
  • PEPG Trial Disappointment: PepGen's Phase 2 Freedom 2 study results showed no significant improvements in walking speed or hand strength at the starting dose of 5 mg/kg, leading to a 45% plunge in premarket trading, reflecting investor disappointment in the therapy's efficacy.
  • SGMO Earnings Miss: Sangamo Therapeutics reported a Q4 loss per share of $0.11, wider than the expected $0.05 loss, despite revenue rising to $14.23 million, indicating pressure on the company's funding outlook that may impact future operations.
  • PHR Revenue Outlook Cut: Phreesia lowered its fiscal 2027 revenue outlook to $510 million to $520 million, below analyst expectations of $552.1 million, resulting in a 27% drop in share price and prompting downgrades from multiple brokerages.
  • Market Sentiment Fluctuates: While retail sentiment for PEPG, SGMO, and PHR on Stocktwits was 'extremely bullish', the disappointing performance and unclear outlook have severely undermined investor confidence, reflecting a cautious attitude towards biotech stocks.
Wall Street analysts forecast PHR stock price to rise
12 Analyst Rating
Wall Street analysts forecast PHR stock price to rise
12 Buy
0 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
24.00
Averages
29.09
High
35.00
Current: 0.000
sliders
Low
24.00
Averages
29.09
High
35.00
Citizens
Outperform
to
Market Perform
downgrade
$NULL
AI Analysis
2026-04-01
New
Reason
Citizens
Price Target
$NULL
AI Analysis
2026-04-01
New
downgrade
Outperform
to
Market Perform
Reason
Citizens downgraded Phreesia to Market Perform from Outperform without a price target. The company's updated fiscal 2027 revenue guidance was disappointing, the analyst tells investors in a research note. The firm now questions Phreesia's ecosystem thesis, saying its growth appears to be "sputtering out" across the largest revenue line in subscription and related services.
Needham
Buy
to
Buy
downgrade
$35 -> $14
2026-03-31
New
Reason
Needham
Price Target
$35 -> $14
2026-03-31
New
downgrade
Buy
to
Buy
Reason
Needham lowered the firm's price target on Phreesia to $14 from $35 and keeps a Buy rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for PHR
Unlock Now

Valuation Metrics

The current forward P/E ratio for Phreesia Inc (PHR.N) is 384.62, compared to its 5-year average forward P/E of -3.05. For a more detailed relative valuation and DCF analysis to assess Phreesia Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-3.05
Current PE
384.62
Overvalued PE
186.89
Undervalued PE
-193.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-28.09
Current EV/EBITDA
-2.11
Overvalued EV/EBITDA
91.58
Undervalued EV/EBITDA
-147.76

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
5.08
Current PS
0.84
Overvalued PS
9.05
Undervalued PS
1.11

Financials

AI Analysis
Annual
Quarterly

Whales Holding PHR

D
Deerfield Management Company, L.P.
Holding
PHR
+6.03%
3M Return
R
Rock Springs Capital Management LP
Holding
PHR
-3.95%
3M Return
G
Greenhouse Funds LLLP
Holding
PHR
-10.86%
3M Return
G
Granahan Investment Management, LLC
Holding
PHR
-12.40%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Phreesia Inc (PHR) stock price today?

The current price of PHR is 8.37 USD — it has decreased -0.36

What is Phreesia Inc (PHR)'s business?

Phreesia, Inc. is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations. The Company's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration, and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. Its Technology solutions segment provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The Company's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.

What is the price predicton of PHR Stock?

Wall Street analysts forecast PHR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PHR is29.09 USD with a low forecast of 24.00 USD and a high forecast of 35.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Phreesia Inc (PHR)'s revenue for the last quarter?

Phreesia Inc revenue for the last quarter amounts to 127.07M USD, increased 15.85

What is Phreesia Inc (PHR)'s earnings per share (EPS) for the last quarter?

Phreesia Inc. EPS for the last quarter amounts to 0.02 USD, decreased -118.18

How many employees does Phreesia Inc (PHR). have?

Phreesia Inc (PHR) has 1789 emplpoyees as of April 02 2026.

What is Phreesia Inc (PHR) market cap?

Today PHR has the market capitalization of 510.41M USD.